Dextrocardia with Situs Inversus
Symptoms, Doctors, Treatments, Advances & More

Dextrocardia with Situs Inversus Overview

Save information for later
Sign Up

Learn About Dextrocardia with Situs Inversus

What is the definition of Dextrocardia with Situs Inversus?
Dextrocardia with situs inversus is a condition that is characterized by abnormal positioning of the heart and other internal organs. In people affected by dextrocardia, the tip of the heart points towards the right side of the chest instead of the left side. Situs inversus refers to the mirror-image reversal of the organs in the chest and abdominal cavity. Some affected people have no obvious signs or symptoms. Dextrocardia with situs inversus can also be associated with primary ciliary dyskinesia (also known as Kartagener syndrome).
What are the alternative names for Dextrocardia with Situs Inversus?
  • Dextrocardia with situs inversus
  • Situs inversus totalis
Who are the top Dextrocardia with Situs Inversus Local Doctors?
Sharon D. Dell
Elite in Dextrocardia with Situs Inversus
Sharon D. Dell
Elite in Dextrocardia with Situs Inversus
Sharon D. Dell
Vancouver, BC, CA 

Sharon Dell practices in Vancouver, Canada. Dell is rated as an Elite expert by MediFind in the treatment of Dextrocardia with Situs Inversus. Their top areas of expertise are Ciliary Dyskinesia-Bronchiectasis, Drug Induced Dyskinesia, Dextrocardia with Situs Inversus, and Dextrocardia.

Jorge R. Alegria
Advanced in Dextrocardia with Situs Inversus
Dr. Jorge R. Alegria
Cardiology
Advanced in Dextrocardia with Situs Inversus
Dr. Jorge R. Alegria
Cardiology

Atrium Health Levine Children's HEARTest Yard Congenital Heart Center

1001 Blythe Blvd., Suite 500, 
Charlotte, NC 
704-373-1813
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Jorge Alegria is a Cardiologist in Charlotte, North Carolina. Dr. Alegria is rated as an Advanced provider by MediFind in the treatment of Dextrocardia with Situs Inversus. His top areas of expertise are Transposition of the Great Arteries, Tetralogy of Fallot, Dextrocardia with Situs Inversus, and Situs Inversus. Dr. Alegria is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Dextrocardia with Situs Inversus
Heymut Omran
Elite in Dextrocardia with Situs Inversus
Heymut Omran
Muenster, NW, DE 

Heymut Omran practices in Muenster, Germany. Omran is rated as an Elite expert by MediFind in the treatment of Dextrocardia with Situs Inversus. Their top areas of expertise are Situs Inversus, Ciliary Dyskinesia-Bronchiectasis, Kartagener Syndrome, and Drug Induced Dyskinesia.

View All Doctors
What are the latest Dextrocardia with Situs Inversus Clinical Trials?
Primary Ciliary Dyskinesias: Identification of Specific Severity Criteria and Phenotype-genotype Correlation Study
Primary Ciliary Dyskinesias: Identification of Specific Severity Criteria and Phenotype-genotype Correlation Study
Enrollment Status: Recruiting
Publish Date: February 12, 2026

Summary: Primary Ciliary Dyskinesias (PCD) are rare, autosomal recessive respiratory diseases, due to a defect in mucociliary clearance linked to abnormalities in the structure and/or function of the cilia. The variety of ciliary abnormalities identified reflects the genetic heterogeneity of PCDs. The thirty or so genes currently implicated explain the pathology in about half of the patients. PCDs are char...

Match to trials
Find the right clinical trials for you in under a minute
Get started
The Ear-Nose-Throat (ENT) Prospective International Cohort of PCD Patients (EPIC-PCD)
The Ear-Nose-Throat (ENT) Prospective International Cohort of PCD Patients (EPIC-PCD)
Enrollment Status: Recruiting
Publish Date: December 02, 2025

Summary: The Ear-Nose-Throat (ENT) Prospective International Cohort of patients with Primary Ciliary Dyskinesia (EPIC-PCD) is a prospective observational clinical cohort study, set up as a multinational multi-centre study. It is embedded into routine patient care of participating reference centres for PCD and patients keep being managed according to local procedures and guidelines.

View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center